Antonio Franco-Vadillo

Dr. Antonio Franco-Vadillo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2021 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
PDF file
AFAntonio Franco-Vadillo
Antonio Franco-Vadillo
MTMireille Toledo‐Blass
Mireille Toledo‐Blass
ZRZeltzin Rivera‐Herrera
Zeltzin Rivera‐Herrera
GGGustavo Guevara‐Balcazar
Gustavo Guevara‐Balcazar
OOOscar Orihuela‐Rodriguez
Oscar Orihuela‐Rodriguez
MCMaría C Castillo-Hernández
María C Castillo-Hernández
Myocardial ischemia continues to be the first cause of morbimortality in the world; the definitive treatment is reperfusion; however, this action causes additional damage to ischemic myocardial tissue; this forces to seek therapies of cardioprotection to reduce this additional damage. There are many cardioprotective agents; within these, cannabinoids have shown to have beneficial effects, mainly cannabidiol (CBD). CBD is a non psychoactive cannabinoid. To evaluate the effect in experimental models of CBD in myocardial ischemia reperfusion in rats, twelve‐week‐old male rats have been used. The animals were divides in 3 groups: control(C), ischemia reperfusion (IR) and CBD pretreatment (1/day/5mg/kg /10days). Langendorff organ isolate studies were performed, and the area of infarction was assessed with triphenyl tetrazolium, in addition to molecular analysis of AT1 and AT2 receptors and Akt and Erk proteins and their phosphorylated forms related to RISK pathways. It was observed that there is an improvement with the use of CBD increasing inotropism and cardiac lusitropism, improving considerably the cardiovascular functionality. These could be related to the reduction of the area of infarction and activation of the AT2 receptor and the RISK pathway with absence of activation of the AT2 receptor (these could relate the reduction of the infarct area and the restoration of cardiovascular function with the activation of the AT2 receptor and the RISK pathway with the absence of activation of the AT2 receptor). The use of cannabinoids was shown to have beneficial effects when used as a treatment for myocardial reperfusion damage.

2 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
Angel Giovanni Arietta GarcíaAngel Giovanni Arietta García
Angel Giovanni Arietta García
Fernando CalzadaFernando Calzada
Fernando Calzada
AFAntonio Franco-Vadillo
Antonio Franco-Vadillo
IBIrais Barrientos-Buendía
Irais Barrientos-Buendía
FAFrancisco Alarcon Aguilar
Francisco Alarcon Aguilar
Rosa María Ordoñez-RazoRosa María Ordoñez-Razo
Rosa María Ordoñez-Razo
Breast cancer (BC) is the most common type of cancer in women worldwide. Hexokinase II (HKII) overexpression is associated with the proliferation and survival of tumor cells, as it inhibits apoptosis. Incomptine A (IA) is cytotoxic to breast cancer cells, likely due to a decrease in the expression of HKII. This study evaluated the antitumor activity of IA in an in vivo mouse model of BC. A model was generated from 4T1 cells and grouped tumor-bearing animals according to treatment: in IA or doxorubicin (DOXO), or untreated (UT). Comparing the body weight and tumor size between groups, tumors were analyzed using histopathological, Western blot, flow cytometry, and mitochondrial activity assays. Tumors IA-treated showed a reduction in size, weight, and number of tumor cells; the expression of HKII and Bcl-2 decreased, while that of Caspase-3 increased. IA treatment increased apoptosis and reduced mitochondrial activity in tumor cells. This data showed that IA has an impact on tumor cells by reducing tumor volume and size, increasing cell apoptosis, and decreasing mitochondrial activity, all of which could be attributed to reduced HKII expression. Therefore, IA may be a promising compound that requires further studies to elucidate its mechanism of action and analyze its possible future use in BC.

9 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
DDDarling Duclosel
Darling Duclosel
AKAlexandre Kormanovski-Kovzova
Alexandre Kormanovski-Kovzova
CCClaudia Carolina Pérez Castro
Claudia Carolina Pérez Castro
JSJan-Hinrich Sick
Jan-Hinrich Sick
AFAntonio Franco-Vadillo
Antonio Franco-Vadillo
EPEleazar Lara Padilla
Eleazar Lara Padilla
Background There is a controversy about the ability of hyperbaric oxygenation to cause oxidative stress in tissues and the multiple data that hyperbaric oxygen preconditioning (HBOP) show a protective effect against oxidative stress in different types of stress or pathologies, including the response to physical stress observed in our previous studies in trained female mice. Methods Utilizing the same animal model, we have investigated in multiple tissues, the effect of the HBOP on the immediate and 24 hours-recovery responses of the redox state parameters, both at basal levels, during the session, and after physical stress. Results It was observed a reduction in the basal levels of tetrahydrobiopterin, nitric oxide, and catalase during a session of HBOP in most tissues, a decrease in the level of reduced glutathione (GSH) in liver, and at the same time its augment in muscle, and intestinal mucosa, being steady in other tissues. The baseline of the redox state for the experimental group returned to or exceeded levels of the control group during recovery for most of the tissues. GSH and related enzymes remained above control in most tissues both during physical stress and after recovery. Conclusion HBOP causes uncoupling of nitric oxide synthases in tissues with a moderate decrease in nitric oxide production and an increase in superoxide anion generation. Superoxide dismutase converts superoxide anion to peroxide resulting in catalase activity wear. It is probably that the decrease in nitric oxide facilitates GSH redistribution from the liver to other tissues, strengthening its antioxidant defense.